Double-Blind Evaluation of Maintenance of Efficacy of Pramipexole Extended-Release in Early Parkinson's Disease

被引：0
|
作者：
Salin, Laurence
Hauser, Robert
Koester, Juergen
机构：
来源：
NEUROLOGY | 2009年 / 72卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：A319 / A319
页数：1
相关论文
共 50 条
  • [41] A double-blind study of the efficacy of venlafaxine extended-release, paroxetine, and placebo in the treatment of panic disorder
    Pollack, Mark H.
    Lepola, Ulla
    Koponen, Hamm
    Simon, Naomi M.
    Worthington, John J.
    Emilien, Gerard
    Tzanis, Evan
    Salinas, Eliseo
    Whitaker, Timothy
    Gao, Bo
    DEPRESSION AND ANXIETY, 2007, 24 (01) : 1 - 14
  • [42] Overnight switch from pramipexole immediate release to pramipexole extended release in patients with early Parkinson's disease: The Switch trial
    Debieuvre, C.
    Salin, L.
    Rascol, O.
    MOVEMENT DISORDERS, 2008, 23 (01) : S201 - S201
  • [43] Success rate, efficacy, and safety/tolerability of overnight switching from immediate-to extended-release pramipexole in advanced Parkinson's disease
    Schapira, A. H. V.
    Barone, P.
    Hauser, R. A.
    Mizuno, Y.
    Rascol, O.
    Busse, M.
    Debieuvre, C.
    Fraessdorf, M.
    Poewe, W.
    EUROPEAN JOURNAL OF NEUROLOGY, 2013, 20 (01) : 180 - 187
  • [44] P2B001 (low dose combination of extended-release pramipexole and rasagiline) versus titrated extended-release pramipexole in the management of early Parkinson's disease: Exploratory findings from a randomized, controlled trial
    Elmer, Lawrence
    Litman, Pninit
    Friedman, Hadas
    Fitzer-Attas, Cheryl
    Oren, Sheila
    NEUROLOGY, 2023, 100 (17)
  • [45] Pramipexole Ameliorates Depression in Parkinson's Disease: A Randomized Double-Blind Versus Placebo Trial
    Barone, Paolo
    Poewe, Werner
    Massey, Dan
    Debieuvre, Catherine Debove
    NEUROLOGY, 2009, 72 (11) : A413 - A413
  • [46] COST-EFFECTIVENESS ANALYSIS OF PRAMIPEXOLE EXTENDED RELEASE MONOTHERAPY IN EARLY PARKINSON'S DISEASE
    Belousov, D.
    Afanasieva, E.
    VALUE IN HEALTH, 2015, 18 (07) : A757 - A757
  • [47] COST-UTILITY ANALYSIS OF PRAMIPEXOLE EXTENDED RELEASE MONOTHERAPY IN EARLY PARKINSON'S DISEASE
    Belousov, D.
    Afanasieva, E.
    VALUE IN HEALTH, 2015, 18 (07) : A758 - A759
  • [48] Efficacy of pramipexole in the treatment of Parkinson's disease:a multi-center,randomized,double-blind,bromocriptine-control trial
    温洪波
    China Medical Abstracts (Internal Medicine), 2006, (04) : 228 - 228
  • [49] A Randomized Phase 3 Study Comparing P2B001 to its Components (Low-Dose Extended-Release Rasagiline and Pramipexole) and to Optimized Doses of Marketed Extended-Release Pramipexole in Early Parkinson's Disease
    Olanow, C. Warren
    Hauser, Robert A.
    Burdick, Daniel J.
    Dhall, Rohit
    de Marcaida, Joy Antonelle
    Gil, Ramon A.
    Kreitzman, David L.
    Elmer, Lawrence W.
    Mcgarry, Andrew
    Kieburtz, Karl
    MOVEMENT DISORDERS, 2024, 39 (02) : 350 - 359
  • [50] Pramipexole Extended Release: A Novel Treatment Option in Parkinson's Disease
    Eisenreich, Wolfram
    Sommer, Bernd
    Hartter, Sebastian
    Jost, Wolfgang H.
    PARKINSONS DISEASE, 2010, 2010
12345